Sarah Doernberg, MD, MAS

Professor

Sarah Doernberg is a Professor in the Division of Infectious Diseases. She has an active outpatient Infectious Diseases Clinic and sees inpatients on the Transplant Infectious Diseases service. Her clinical research focuses on diagnosis and treatment of antibiotic resistant infections.

She received her BA from Harvard University in Biology with a focus in Neurobiology and received her MD from Yale University School of Medicine. She completed her Internal Medicine residency and Infectious Diseases fellowship at UCSF. She also received a Masters’ degree in advanced studies through the Training in Clinical Research Program at UCSF.
Education
2020 - Diversity, Equity, and Inclusion Champion Training, University of California
Fellowship, 2012 - Clinical Pharmacology and Therapeutics, University of California, San Francisco
M.A.S. in Clinical Research, 2012 - Graduate Division (Advance Training in Clinical Research), University of California, San Francisco
Fellowship, 2012 - Infectious Diseases, University of California, San Francisco
Residency, 2009 - Internal Medicine, University of California, San Francisco
M.D., 2006 - School of Medicine, Yale University
Publications

  1. Kinamon T, Waack U, Needles M, Rubin D, Collyar D, Doernberg SB, Evans SR, Hamasaki T, Holland TL, Howard-Anderson J, Chambers H, Fowler VG, Nambiar S, Kim P, Boucher HW, Gopinath R. Exploration of a Potential DOOR Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs. 2024. PMID: 38527855


  2. Bond A, Oreper S, Prasad P, Abdoler E, Doernberg S. Development of antibiotic metrics for hospitalists via multi-institutional modified Delphi survey. 2024. PMID: 38698571


  3. Minter DJ, Appa A, Chambers HF, Doernberg SB. The positioning of ceftobiprole in the treatment of Staphylococcus aureus bacteremia. 2024. PMID: 38466317


  4. Paules CI, Wang J, Tomashek KM, Bonnett T, Singh K, Marconi VC, Davey RT, Lye DC, Dodd LE, Yang OO, Benson CA, Deye GA, Doernberg SB, Hynes NA, Grossberg R, Wolfe CR, Nayak SU, Short WR, Voell J, Potter GE, Rapaka RR. A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2. 2024. PMID: 38408357


  5. Howard-Anderson J, Hamasaki T, Dai W, Collyar D, Rubin D, Nambiar S, Kinamon T, Leister-Tebbe H, Hill C, Geres H, Holland TL, Doernberg SB, Chambers HF, Fowler VG, Evans SR, Boucher HW. Moving beyond mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia. 2023. PMID: 37740559


  7. Bystritsky R, Gruenberg K, Abdoler E, Hilts-Horeczko A, Doernberg SB. Inter-rater reliability assessment of antibiotic prescription quality by infectious diseases physicians, fellows, and pharmacists. 2023. PMID: 38156222


  8. Minter DJ, Appa A, Chambers HF, Doernberg SB. Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice. 2023. PMID: 37950887


  11. Hanson KE, Banerjee R, Doernberg SB, Evans SR, Komarow L, Satlin MJ, Schwager N, Simner PJ, Tillekeratne LG, Patel R, Antibacterial Resistance Leadership Group. Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group. 2023. PMID: 37843119


  12. Doernberg SB, Arias CA, Altman DR, Babiker A, Boucher HW, Creech CB, Cosgrove SE, Evans SR, Fowler VG, Fritz SA, Hamasaki T, Kelly BJ, Leal SM, Liu C, Lodise TP, Miller LG, Munita JM, Murray BE, Pettigrew MM, Ruffin F, Scheetz MH, Shopsin B, Tran TT, Turner NA, Williams DJ, Zaharoff S, Holland TL, Antibacterial Resistance Leadership Group. Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review. 2023. PMID: 37843115


  13. Green SI, Clark JR, Santos HH, Weesner KE, Salazar KC, Aslam S, Campbell WJ, Doernberg SB, Blodget E, Morris MI, Suh GA, Obeid K, Silveira FP, Filippov AA, Whiteson KL, Trautner BW, Terwilliger AL, Maresso A. A retrospective, observational study of 12 cases of expanded access customized phage therapy: production, characteristics, and clinical outcomes. 2023. PMID: 37279523


  14. Holland TL, Cosgrove SE, Doernberg SB, Jenkins TC, Turner NA, Boucher HW, Pavlov O, Titov I, Kosulnykov S, Atanasov B, Poromanski I, Makhviladze M, Anderzhanova A, Stryjewski ME, Assadi Gehr M, Engelhardt M, Hamed K, Ionescu D, Jones M, Saulay M, Smart J, Seifert H, Fowler VG, ERADICATE Study Group. Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia. 2023. PMID: 37754204


  15. Nelson GE, Narayanan N, Onguti S, Stanley K, Newland JG, Doernberg SB. Principles and Practice of Antimicrobial Stewardship Program Resource Allocation. 2023. PMID: 37735012


  16. Kinamon T, Gopinath R, Waack U, Needles M, Rubin D, Collyar D, Doernberg SB, Evans S, Hamasaki T, Holland TL, Howard-Anderson J, Chambers H, Fowler VG, Nambiar S, Kim P, Boucher HW. Exploration of a Potential DOOR Endpoint for Complicated Intra-Abdominal Infections Using Nine Registrational Trials for Antibacterial Drugs. 2023. PMID: 37073571


  17. Otani IM, Tang M, Wang L, Anstey KM, Hilts-Horeczko A, Li F, Le VP, Lee M, Bystritsky R, Mulliken JS, Wattier RL, Blumenthal KG, Doernberg SB. Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use. 2023. PMID: 37182569


  18. Nguyen MT, Mentreddy A, Schallhorn J, Chan M, Aung S, Doernberg SB, Babik J, Miles K, Yang K, Lydon E, Minter DJ, Gonzales J, Shantha J, Doan T, Seitzman GD. Isolated Ocular Mpox without Skin Lesions, United States. 2023. PMID: 37130504


  19. Mulliken JS, Hampshire KN, Rappold AG, Fung M, Babik JM, Doernberg SB. Risk of systemic fungal infections after exposure to wildfires: a population-based, retrospective study in California. 2023. PMID: 37164514


  20. Patel R, Tsalik EL, Evans S, Fowler VG, Doernberg SB, Antibacterial Resistance Leadership Group. Clinically Adjudicated Reference Standards for Evaluation of Infectious Diseases Diagnostics. 2022. PMID: 36262037


  21. Howard-Anderson J, Hamasaki T, Dai W, Collyar D, Rubin D, Nambiar S, Kinamon T, Hill C, Gelone SP, Mariano D, Baba T, Holland TL, Doernberg SB, Chambers HF, Fowler VG, Evans SR, Boucher HW. Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Complicated Urinary Tract Infection Clinical Trials. 2022. PMID: 36031403


  22. Fung M, DeVoe C, Spottiswoode N, Doernberg SB. Maribavir for Cytomegalovirus Treatment in the Real World-Not a Silver Bullet. 2022. PMID: 36632422


  23. Tori Kinamon, Ramya Gopinath, Ursula Waack, Mark Needles, Daniel Rubin, Deborah Collyar, Sarah B Doernberg, Scott R Evans, Toshimitsu Hamasaki, Thomas L Holland, Jessica Howard-Anderson, Henry Chambers, Vance G Fowler, Sumathi Nambiar, Peter Kim, Helen W Boucher. 223. Development and Analysis of a Novel DOOR Endpoint for Complicated Intra-abdominal Infections (cIAI) Using 10 Registrational Trials for Antibacterial Drugs. 2022. PMID:


  24. Thomas L Holland, Sara E Cosgrove, Sarah B Doernberg, Oleksander Pavlov, Ivan Titov, Boyko Atanasov, Maziar Assadi Gehr, Marc Engelhardt, Kamal Hamed, Daniel Ionescu, Mark Jones, Mikael Sauley, Jennifer Smart, Harald Seifert, Timothy C Jenkins, Nicholas A Turner, Vance G Fowler. LB2302. Ceftobiprole Compared to Daptomycin With or Without Optional Aztreonam for the Treatment of Complicated Staphylococcus aureus (SAB): Results of a Phase 3, Randomized, Double-Blind Trial (ERADICATE). 2022. PMID:


  25. Potter GE, Bonnett T, Rubenstein K, Lindholm DA, Rapaka RR, Doernberg SB, Lye DC, Mularski RA, Hynes NA, Kline S, Paules CI, Wolfe CR, Frank MG, Rouphael NG, Deye GA, Sweeney DA, Colombo RE, Davey RT, Mehta AK, Whitaker JA, Castro JG, Amin AN, Colombo CJ, Levine CB, Jain MK, Maves RC, Marconi VC, Grossberg R, Hozayen S, Burgess TH, Atmar RL, Ganesan A, Gomez CA, Benson CA, Lopez de Castilla D, Ahuja N, George SL, Nayak SU, Cohen SH, Lalani T, Short WR, Erdmann N, Tomashek KM, Tebas P. Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial. 2022. PMID: 36442063


  26. Doernberg SB, Holubar M, Jain V, Weng Y, Lu D, Bollyky JB, Sample H, Huang B, Craik CS, Desai M, Rutherford GW, Maldonado Y, CHART Study Consortium. Incidence and prevalence of COVID-19 within a healthcare worker cohort during the first year of the SARS-CoV-2 pandemic. 2022. PMID: 35279023


  27. Kalantar KL, Neyton L, Abdelghany M, Mick E, Jauregui A, Caldera S, Serpa PH, Ghale R, Albright J, Sarma A, Tsitsiklis A, Leligdowicz A, Christenson SA, Liu K, Kangelaris KN, Hendrickson C, Sinha P, Gomez A, Neff N, Pisco A, Doernberg SB, Derisi JL, Matthay MA, Calfee CS, Langelier CR. Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults. 2022. PMID: 36266337


  28. Leibovici L, Paul M, Doernberg SB. Which randomized controlled trial do we need? 2022. PMID: 36216239


  29. Doernberg SB, MAS for the Antibacterial Resistance Leadership Group. Desirability of outcome ranking and quality life measurement for antimicrobial research in organ transplantation. 2022. PMID: 35748640


  30. Serpa PH, Deng X, Abdelghany M, Crawford E, Malcolm K, Caldera S, Fung M, McGeever A, Kalantar KL, Lyden A, Ghale R, Deiss T, Neff N, Miller SA, Doernberg SB, Chiu CY, DeRisi JL, Calfee CS, Langelier CR. Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections. 2022. PMID: 35818068


  31. Wolfe CR, Tomashek KM, Patterson TF, Gomez CA, Marconi VC, Jain MK, Yang OO, Paules CI, Palacios GMR, Grossberg R, Harkins MS, Mularski RA, Erdmann N, Sandkovsky U, Almasri E, Pineda JR, Dretler AW, de Castilla DL, Branche AR, Park PK, Mehta AK, Short WR, McLellan SLF, Kline S, Iovine NM, El Sahly HM, Doernberg SB, Oh MD, Huprikar N, Hohmann E, Kelley CF, Holodniy M, Kim ES, Sweeney DA, Finberg RW, Grimes KA, Maves RC, Ko ER, Engemann JJ, Taylor BS, Ponce PO, Larson L, Melendez DP, Seibert AM, Rouphael NG, Strebe J, Clark JL, Julian KG, de Leon AP, Cardoso A, de Bono S, Atmar RL, Ganesan A, Ferreira JL, Green M, Makowski M, Bonnett T, Beresnev T, Ghazaryan V, Dempsey W, Nayak SU, Dodd LE, Beigel JH, Kalil AC, ACTT-4 Study Group. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. 2022. PMID: 35617986


  32. Turner NA, Zaharoff S, King H, Evans S, Hamasaki T, Lodise T, Ghazaryan V, Beresnev T, Riccobene T, Patel R, Doernberg SB, Rappo U, Fowler VG, Holland TL, Antibacterial Resistance Leadership Group (ARLG). Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial. 2022. PMID: 35578360


  33. Bergas A, Albasanz-Puig A, Fernández-Cruz A, Machado M, Novo A, van Duin D, Garcia-Vidal C, Hakki M, Ruiz-Camps I, Del Pozo JL, Oltolini C, DeVoe C, Drgona L, Gasch O, Mikulska M, Martín-Dávila P, Peghin M, Vázquez L, Laporte-Amargós J, Durà-Miralles X, Pallarès N, González-Barca E, Álvarez-Uría A, Puerta-Alcalde P, Aguilar-Company J, Carmona-Torre F, Clerici TD, Doernberg SB, Petrikova L, Capilla S, Magnasco L, Fortún J, Castaldo N, Carratalà J, Gudiol C. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study). 2022. PMID: 35475683


  34. Howard-Anderson J, Dai W, Yahav D, Hamasaki T, Turjeman A, Koppel F, Franceschini E, Hill C, Sund Z, Chambers HF, Fowler VG, Boucher HW, Evans SR, Paul M, Holland TL, Doernberg SB. A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection. 2022. PMID: 35615299


  35. Paules CI, Gallagher SK, Rapaka RR, Davey RT, Doernberg SB, Grossberg R, Hynes NA, Ponce P, Short WR, Voell J, Wang J, Yang OO, Wolfe CR, Lye DC, Dodd LE, Benson CA. Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data. 2021. PMID: 34379740


  36. Iris Otani, Monica Tang, Karen Anstey, Lusha Wang, Alexandra Hilts-Horeczko, Fanny Li, Vincent Le, Melissa Lee, Jennifer Mulliken, Rachel Bystritsky, Sarah Doernberg. Implementing a Hospital-Wide Inpatient Beta-Lactam Allergy Guideline Leads to Consistent Increases in Beta-Lactam Use. 2022. PMID:


  37. Chan JL, Nazarian E, Musser KA, Snavely EA, Fung M, Doernberg SB, Pouch SM, Leekha S, Anesi JA, Kodiyanplakkal RP, Turbett SE, Walters MS, Epstein L. Prevalence of carbapenemase-producing organisms among hospitalized solid organ transplant recipients, five U.S. hospitals, 2019-2020. 2022. PMID: 34989092


  38. Appa A, Adamo M, Le S, Davis J, Winston L, Doernberg SB, Chambers H, Martin M, Hills NK, Coffin PO, Jain V. Comparative one-year outcomes of invasive Staphylococcus aureus infections among persons with and without drug use: an observational cohort study. 2021. PMID: 33904900


  39. King HA, Doernberg SB, Grover K, Miller J, Oakes M, Wang TW, McFatrich M, Ruffin F, Staman K, Lane HG, Rader A, Sund Z, Bosworth HB, Reeve BB, Fowler VG, Holland TL. Patients' Experiences With Staphylococcus aureus and Gram-Negative Bacterial Bloodstream Infections: Results From Cognitive Interviews to Inform Assessment of Health-Related Quality of Life. 2021. PMID: 35106313


  40. Weng Y, Lu D, Bollyky J, Jain V, Desai M, Lindan C, Boothroyd D, Judson T, Doernberg SB, Holubar M, Sample H, Huang B, Maldonado Y, Rutherford GW, Grumbach K. Race-ethnicity and COVID-19 Vaccination Beliefs and Intentions: A Cross-Sectional Study among the General Population in the San Francisco Bay Area. 2021. PMID: 34960152


  41. Kalil AC, Mehta AK, Patterson TF, Erdmann N, Gomez CA, Jain MK, Wolfe CR, Ruiz-Palacios GM, Kline S, Regalado Pineda J, Luetkemeyer AF, Harkins MS, Jackson PEH, Iovine NM, Tapson VF, Oh MD, Whitaker JA, Mularski RA, Paules CI, Ince D, Takasaki J, Sweeney DA, Sandkovsky U, Wyles DL, Hohmann E, Grimes KA, Grossberg R, Laguio-Vila M, Lambert AA, Lopez de Castilla D, Kim E, Larson L, Wan CR, Traenkner JJ, Ponce PO, Patterson JE, Goepfert PA, Sofarelli TA, Mocherla S, Ko ER, Ponce de Leon A, Doernberg SB, Atmar RL, Maves RC, Dangond F, Ferreira J, Green M, Makowski M, Bonnett T, Beresnev T, Ghazaryan V, Dempsey W, Nayak SU, Dodd L, Tomashek KM, Beigel JH, ACTT-3 study group members. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. 2021. PMID: 34672949


  42. Appa A, Adamo M, Le S, Davis J, Winston L, Doernberg SB, Chambers H, Martin M, Hills NK, Coffin P, Jain V. Patient-Directed Discharges Among Persons Who Use Drugs Hospitalized with Invasive S. aureus Infections: Opportunities for Improvement. 2021. PMID: 34508704


  43. Jain V, Doernberg SB, Holubar M, Huang B, Bollyky J, Sample H, Weng Y, Lu D, Desai M, Maldonado Y, Rutherford G. High Completion of COVID-19 Vaccination Among Health Care Workers Despite Initial Self-Reported Vaccine Reluctance. 2021. PMID: 34734101


  44. Bainbridge ED, Hsue PY, Esensten JH, Lynch KL, Hendrickson CM, Doernberg SB, Fung M, Chin-Hong P, Di Germanio C, Norris PJ, Simmons G, Glidden DV, Luetkemeyer AF. Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019. 2021. PMID: 34405093


  45. King HA, Doernberg SB, Miller J, Grover K, Oakes M, Ruffin F, Gonzales S, Rader A, Neuss MJ, Bosworth HB, Sund Z, Drennan C, Hill-Rorie JM, Shah P, Winn L, Fowler VG, Holland TL. Patients' Experiences With Staphylococcus aureus and Gram-negative Bacterial Bloodstream Infections: A Qualitative Descriptive Study and Concept Elicitation Phase To Inform Measurement of Patient-reported Quality of Life. 2021. PMID: 32445467


  47. Banerjee R, Komarow L, Virk A, Rajapakse N, Schuetz AN, Dylla B, Earley M, Lok J, Kohner P, Ihde S, Cole N, Hines L, Reed K, Garner OB, Chandrasekaran S, de St Maurice A, Kanatani M, Curello J, Arias R, Swearingen W, Doernberg SB, Patel R. Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN. 2021. PMID: 32374822


  48. Anstey KM, Anstey JE, Doernberg SB, Chen LL, Otani IM. Perioperative use and safety of cephalosporin antibiotics in patients with documented penicillin allergy. 2021. PMID: 33766583


  49. Bond AR, Bainbridge E, Doernberg SB, Babik JM, Miller S, Khanafshar E, Henry T, David A, Russell M, Brandman D, Sherman CB, Yao F, Fung M. Disseminated Legionella micdadei Infection in a Liver Transplant Patient Presenting as Pulmonary Nodules and a Laryngeal Lesion. 2021. PMID: 33434394


  50. Trinh TD, Strnad L, Damon L, Dzundza JH, Graff LR, Griffith LM, Hilts-Horeczko A, Olin R, Shenoy S, DeVoe C, Wang L, Rodriguez-Monguio R, Gu TM, Hampton SR, Macapinlac BAC, Yang K, Doernberg SB. Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis. 2021. PMID: 33487182


  51. Ayesha Ashley Appa, Meredith Adamo, Stephenie Le, Jennifer Davis, Lisa Gail Winston, Sarah B Doernberg, Henry Chambers, Marlene Martin, Phillip Coffin, Vivek Jain. 39. Comparative One-year Outcomes of Invasive staphylococcus Aureus infections Among Persons with and Without Drug Use in an Urban West Coast Cohort. 2020. PMID:


  52. June L Chan, Elizabeth Nazarian, Kimberlee A Musser, Monica Fung, Sarah B Doernberg, Stephanie M Pouch, Stephanie M Pouch, Surbhi Leekha, Judith A Anesi, Rosy Priya Kodiyanplakkal, Sarah Turbett, Maroya Spalding Walters, Lauren Epstein, Lauren Epstein. 918. Pilot Surveillance for Carbapenemase Gene-positive Organisms Among Hospitalized Solid Organ Transplant Recipients. 2020. PMID:


  53. Rowe TA, Jump RLP, Andersen BM, Banach DB, Bryant KA, Doernberg SB, Loeb M, Morgan DJ, Morris AM, Murthy RK, Nace DA, Crnich CJ. Reliability of nonlocalizing signs and symptoms as indicators of the presence of infection in nursing-home residents. 2020. PMID: 33292915


  54. Doernberg SB, Komarow L, Tran TTT, Sund Z, Pandori MW, Jensen D, Tsalik EL, Deal CD, Chambers HF, Fowler VG, Evans SR, Patel R, Klausner JD. Simultaneous Evaluation of Diagnostic Assays for Pharyngeal and Rectal Neisseria gonorrhoeae and Chlamydia trachomatis Using a Master Protocol. 2020. PMID: 31734695


  55. Mummaneni PV, Burke JF, Chan AK, Sosa JA, Lobo EP, Mummaneni VP, Antrum S, Berven SH, Conte MS, Doernberg SB, Goldberg AN, Hess CP, Hetts SW, Josephson SA, Kohi MP, Ma CB, Mahadevan VS, Molinaro AM, Murr AH, Narayana S, Roberts JP, Stoller ML, Theodosopoulos PV, Vail TP, Wienholz S, Gropper MA, Green A, Berger MS. Consensus-based perioperative protocols during the COVID-19 pandemic. 2020. PMID: 33007752


  56. Hao S, Abdelghany M, Lyden A, Sit R, Tan M, Tato CM, DeRisi JL, Miller S, Doernberg SB, Langelier C. Genomic Profiling of Evolving Daptomycin Resistance in a Patient with Recurrent Staphylococcus argenteus Sepsis. 2020. PMID: 32601156


  57. Fung M, Chiu CY, DeVoe C, Doernberg SB, Schwartz BS, Langelier C, Henrich TJ, Yokoe D, Davis J, Hays SR, Chandran S, Kukreja J, Ng D, Prostko J, Taylor R, Reyes K, Bainbridge E, Bond A, Chin-Hong P, Babik JM. Clinical Outcomes and Serologic Response in Solid Organ Transplant Recipients with COVID-19: A Case Series from the United States. 2020. PMID: 32476258


  59. Adamson PC, Pandori MW, Doernberg SB, Komarow L, Sund Z, Tran TTT, Jensen D, Tsalik EL, Deal CD, Chambers HF, Fowler VG, Evans SR, Patel R, Klausner JD. Analytical evaluation of the Abbott RealTime CT/NG Assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in rectal and pharyngeal swabs. 2020. PMID: 32247863


  61. Trang D Trinh, Luke Strnad, Lloyd E Damon, John H Dzundza, Larissa R Graff, Laura M Griffith, Alexandra Hilts-Horeczko, Rebecca L Olin, Samantha Shenoy, Catherine DeVoe, Lusha Wang, Rosa Rodriguez-Monguio, Sarah B Doernberg. 1089. Implementation of a Febrile Neutropenia Management Algorithm on Antibiotic Use and Outcomes: An Interrupted Time Series Analysis. 2019. PMID:


  62. Jennifer S Mulliken, Rachel Bystritsky, Karen Anstey, Iris M Otani, Sarah B Doernberg. 2543. Implementation of a Fellow-Driven ?-Lactam Allergy De-Labeling Initiative on an Inpatient ID Consult Service. 2019. PMID:


  63. Catherine DeVoe, Trang D Trinh, Joshua Moises, Binh C Pham, Allen V Tran, Lisa Vuong, Sarah B Doernberg. 2685. Oral Third-Generation Cephalosporins vs. Levofloxacin for Antibacterial Prophylaxis in Neutropenic Patients with Hematologic Malignancies. 2019. PMID:


  64. Ritu Banerjee, Ritu Banerjee, Lauren Komarow, Abinash Virk, Nipunie S Rajapakse, Audrey Schuetz, Brenda Dylla, Michelle Earley, Judith Lok, Peggy Kohner, Sherry Ihde, Nicolynn Cole, Lisa Hines, Katelyn Reed, Omai Garner, Sukantha Chandrasekaran, Annabelle M de St. Maurice, Meganne Kanatani, Jennifer Curello, Rubi Arias, William Swearingen, Sarah B Doernberg, Robin Patel, Robin Patel. 640. Randomized Clinical Trial Evaluating Clinical Impact of RAPid IDentification and Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia (RAPIDS-GN). 2019. PMID:


  65. Christopher R Polage, Jonathan Grein, Margie Morgan, Sarah B Doernberg, Steve Miller, Raymond Chinn, Cathy Woerle, Jennifer Yim, Cassiana Bittencourt, Sneha Krishna, Nicolle Anne Ocampo, Laurel Gibbs, Shannon C Mabalot, Kathleen A Quan, Usme Khusbu, Keith M Madey, Czarina Ganzon, Fatemeh Memar, Christian B Pascual, Stuart Cohen, Catherine Liu, Deborah S Yokoe, Susan S Huang. 839. Effect of Clostridioides difficile (C. difficile) Toxin Test Reporting on Clinical Treatment and Outcomes of Toxin-Negative PCR-Positive Patients at Five California Hospitals. 2019. PMID:


  66. Woodworth MH, Dynerman D, Crawford ED, Doernberg SB, Ramirez-Avila L, Serpa PH, Nichols A, Li LM, Lyden A, Tato CM, Miller S, Derisi JL, Langelier C. Sentinel Case of Candida auris in the Western United States Following Prolonged Occult Colonization in a Returned Traveler from India. 2019. PMID: 31163013


  67. Evans SR, Follmann D, Liu Y, Holland T, Doernberg SB, Rouphael N, Hamasaki T, Jiang Y, Lok JJ, Tran TTT, Harris AD, Fowler VG, Boucher H, Kreiswirth BN, Bonomo RA, Van Duin D, Paterson DL, Chambers H. Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS). 2019. PMID: 30351426


  68. Doernberg SB, Tran TTT, Tong SYC, Paul M, Yahav D, Davis JS, Leibovici L, Boucher HW, Corey GR, Cosgrove SE, Chambers HF, Fowler VG, Evans SR, Holland TL. Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection. 2018. PMID: 30321315


  69. Young K, Doernberg SB, Snedecor RF, Mallin E. Things We Do For No Reason: Contact Precautions for MRSA and VRE. 2019. PMID: 30811326


  70. Karen Anstey, James Anstey, Alexandra Hilts-Horeczko, Sarah B. Doernberg, Lee-Lynn Chen, Iris M. Otani. Perioperative Use and Safety of Cephalosporin Antibiotics in Patients with Documented Penicillin Allergy. 2019. PMID:


  71. Rachel Bystritsky, Albert T Young, Andrew Wong, Alexandra Hilts-Horeczko, Conan Macdougall, Henry F Chambers, Sarah B Doernberg. 1818. Characteristics of a Cohort of Patients on Broad-Spectrum Antibiotics Targeted for Prospective Audit and Feedback. 2018. PMID:


  72. Catherine DeVoe, Monica Fung, Brian Schwartz, Sarah B Doernberg, Mimi Lo, Larissa Graff, Marisela Tan, Aaron Logan, Jennifer Babik, Peter Chin-Hong. 415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis. 2018. PMID:


  73. Doernberg SB, Abbo LM, Burdette SD, Fishman NO, Goodman EL, Kravitz GR, Leggett JE, Moehring RW, Newland JG, Robinson PA, Spivak ES, Tamma PD, Chambers HF. Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting. 2018. PMID: 29590355


  74. Fung M, Schwartz BS, Doernberg SB, Langelier C, Lo M, Graff L, Tan M, Logan AC, Chin-Hong P, Babik JM. Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting? 2018. PMID: 29617983


  75. Wilson MR, O'Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, Shah MP, Richie MB, Gorman MP, Hajj-Ali RA, Calabrese LH, Zorn KC, Chow ED, Greenlee JE, Blum JH, Green G, Khan LM, Banerji D, Langelier C, Bryson-Cahn C, Harrington W, Lingappa JR, Shanbhag NM, Green AJ, Brew BJ, Soldatos A, Strnad L, Doernberg SB, Jay CA, Douglas V, Josephson SA, DeRisi JL. Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing. 2018. PMID: 29710329


  77. Doernberg SB, Chambers HF. Antimicrobial Stewardship Approaches in the Intensive Care Unit. 2017. PMID: 28687210


  78. Doernberg SB, Lodise TP, Thaden JT, Munita JM, Cosgrove SE, Arias CA, Boucher HW, Corey GR, Lowy FD, Murray B, Miller LG, Holland TL, Gram-Positive Committee of the Antibacterial Resistance Leadership Group (ARLG). Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group. 2017. PMID: 28350900


  79. Brondfield MN, Reid MJ, Rutishauser RL, Cope JR, Tang J, Ritter JM, Matanock A, Ali I, Doernberg SB, Hilts-Horeczko A, DeMarco T, Klein L, Babik JM. Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature. 2017. PMID: 28067969


  80. Thomas L Holland, Joshua S Davis, Sarah B Doernberg, Thuy Tien T Tran, Scott R Evans, Sara E Cosgrove, Helen W Boucher, G Ralph Corey, Vance Fowler, Henry F Chambers, Steven Y. C Tong. Analysis of CAMERA-1 S. aureus Bacteremia Trial Results Using the DOOR. 2017. PMID:


  81. Alexandra M. Hanretty, Sarah B. Doernberg, Alexandra Hilts-Horeczko. Assessing the Impact of a Pharmacist-Managed Vancomycin Protocol on the Duration of Empiric Therapy. 2016. PMID:


  83. Sarah Doernberg, Natalia Gouskova, Scott Evans, Helen Boucher, G. Corey, Sara Cosgrove, Henry Chambers, Vance Fowler, Thomas Holland. BAC DOOR: A Clinician Ranking Exercise for Better Staphylococcus aureus Bacteremia Trial Design. 2016. PMID:


  84. Baxi SM, Robinson ML, Grill MF, Schwartz BS, Doernberg SB, Liu C. Clinical Characteristics and Outcomes Among Individuals With Spinal Implant Infections: A Descriptive Study. 2016. PMID: 27704027


  85. Baxi SM, Clemenzi-Allen A, Gahbauer A, Deck D, Imp B, Vittinghoff E, Chambers HF, Doernberg S. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia. 2016. PMID: 27324762


  86. Pollett S, Baxi SM, Rutherford GW, Doernberg SB, Bacchetti P, Chambers HF. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center. 2016. PMID: 27216053


  88. Sanjiv Baxi, Angelo Clemenzi-Allen, Alice Gahbauer, Daniel Deck, Brandon Imp, Sarah Doernberg, Henry F. Chambers. 724Vancomycin Minimum Inhibitory Concentration Does Not Predict Death, Recurrence or Readmission in Patients with Staphylococcus aureus Bacteremia in a Safety-Net Hospital. 2014. PMID:


  89. Angelo Clemenzi-Allen, Sanjiv Baxi, Alice Gahbauer, Brandon Imp, Daniel Deck, Sarah Doernberg, Henry F. Chambers. 727Evaluating the Impact of Socioeconomic Status on Clinical Presentation in Patients with Staphylococcus aureus Bacteremia. 2014. PMID:


  90. Doernberg SB, Winston LG, Deck DH, Chambers HF. Does doxycycline protect against development of Clostridium difficile infection? 2012. PMID: 22563022


  92. Doernberg S, Schaaf B, Dalhoff K, Leng L, Beitin A, Quagliarello V, Bucala R. Association of macrophage migration inhibitory factor (MIF) polymorphisms with risk of meningitis from Streptococcus pneumoniae. 2011. PMID: 21208809


  93. Sarah Doernberg, Richard Bucala. CHAPTER 151 The Macrophage in Innate and Adaptive Immunity. 2009. PMID: